What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His main research concerns Surgery, Chemotherapy, Internal medicine, Oncology and Sarcoma.
The various areas that Michael P. Link examines in his Surgery study include Osteosarcoma and Lymphoma.
His studies deal with areas such as Regimen, Primary tumor and Radiation therapy as well as Chemotherapy.
Many of his studies involve connections with topics such as Gastroenterology and Internal medicine.
As a part of the same scientific study, Michael P. Link usually deals with the Oncology, concentrating on Etoposide and frequently concerns with Melphalan, Univariate analysis and Rhabdomyosarcoma.
His work in the fields of Sarcoma, such as Ewing's sarcoma, Primitive neuroectodermal tumor and Neuroectodermal tumor, intersects with other areas such as Subset Analysis.
His most cited work include:
- Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. (916 citations)
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity (862 citations)
- Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. (717 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Surgery, Oncology, Chemotherapy and Pathology.
His studies link Gastroenterology with Internal medicine.
Michael P. Link combines subjects such as Osteosarcoma, Clinical trial, Rhabdomyosarcoma and Lymphoma with his study of Surgery.
His research in Oncology focuses on subjects like Sarcoma, which are connected to Cancer.
Michael P. Link interconnects Regimen, Methotrexate and Radiation therapy in the investigation of issues within Chemotherapy.
The Pathology study combines topics in areas such as Immunophenotyping and Cytogenetics.
He most often published in these fields:
- Internal medicine (46.99%)
- Surgery (33.73%)
- Oncology (30.12%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (46.99%)
- Oncology (30.12%)
- Surgery (33.73%)
In recent papers he was focusing on the following fields of study:
Michael P. Link spends much of his time researching Internal medicine, Oncology, Surgery, Young adult and Lymphoma.
Michael P. Link combines Internal medicine and MISMATCH REPAIR DEFICIENCY in his research.
His Oncology research incorporates themes from Cancer, Survival benefit, Vincristine and Brentuximab vedotin, Hodgkin lymphoma.
In general Surgery study, his work on Chemotherapy, Autologous transplantation and Cyclophosphamide often relates to the realm of Watchful waiting, thereby connecting several areas of interest.
His Chemotherapy research incorporates elements of Asymptomatic, Radiation therapy and Prednisone.
Michael P. Link works mostly in the field of Pathology, limiting it down to concerns involving Follicular dendritic cells and, occasionally, Leukemia.
Between 2011 and 2021, his most popular works were:
- Adolescent and young adult oncology. Clinical practice guidelines in oncology. (144 citations)
- In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs (101 citations)
- Adolescent and young adult oncology, version 2.2014: Featured updates to the NCCN guidelines (89 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Michael P. Link mainly investigates Young adult, Internal medicine, Psychosocial, Oncology and Cancer.
Michael P. Link works mostly in the field of Young adult, limiting it down to topics relating to Fertility preservation and, in certain cases, Cause of death, Family medicine, Adolescent medicine and Pregnancy.
His research on Internal medicine often connects related topics like Surgery.
His Surgery research integrates issues from Magnetic resonance imaging and Ferumoxytol.
Michael P. Link has included themes like Fertility, Regimen, Cyclophosphamide and Lymphoma, Hodgkin lymphoma in his Oncology study.
The concepts of his Cancer study are interwoven with issues in Childhood leukemia and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
